ArticleClinical and translational medicine2022

Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers.

Yu-Wei Hsiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.